Petra Acquisition Inc

NASDAQ:PAIC   10:20:10 AM EDT
10.10
-0.02 (-0.20%)
Products, Regulatory

Revelation Biosciences Inc. Receives Approval To Initiate Phase 2B Viral Challenge Study Of Revtx 99

Published: 09/28/2021 13:41 GMT
Petra Acquisition Inc (PAIC) - Revelation Biosciences - Phase 2b Study Will Investigate Efficacy of Revtx-99 on Viral Load and Patient-reported Flu Symptoms.
Revelation Biosciences, Which is Merging With Petra Acquisition, Says Top-line Data Anticipated in Q2 of 2022 .
Revelation Biosciences Inc. Receives Approval to Initiate Phase 2b Viral Challenge Study of Revtx 99, an Experimental Prophylactic Treatment for Prevention of Respiratory Viral Infections.